XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$64.17
-0.13 (-0.20%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
-68.9% upside
Low Target
$12.55
Average Target
$19.98
High Target
$22.13
Current Price
$64.17
Current
$64.17
$64.17
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Scenario Analysis
Bear Case
$12.55
-80.4%
Low target
Base Case
$19.98
-68.9%
Avg target
Bull Case
$22.13
+-65.5%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$72.66
-11.7% from high
52-Week Low
$30.00
+113.9% from low
50-Day SMA
$42.54
+50.8% vs SMA
200-Day SMA
$37.78
+69.9% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$19.98
-72.5% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
4d
until earnings
EPS Est: $-1.16
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |